Literature DB >> 20536738

Progressive renal vascular proliferation and injury in obese Zucker rats.

Radu Iliescu1, Alejandro R Chade.   

Abstract

OBJECTIVE: Obesity, an independent risk factor for chronic kidney disease, may induce renal injury by promoting inflammation. Inflammatory cytokines can induce neovascularization in different organs, including the kidneys. However, whether obesity triggers renal neovascularization and, if so, its effect on renal function has never been investigated.
METHODS: Blood pressure, proteinuria, and glomerular filtration rate (GFR) were measured in vivo. Renal microvascular (MV) architecture was studied by 3D micro-CT in lean and obese Zucker rats (LZR and OZR, n = 7/group) at 12, 22, and 32 weeks of age. Renal inflammation was assessed by quantifying interleukin (IL)-6, tumor necrosis factor (TNF)-alpha, and ED-1 expression, as renal fibrosis in trichrome-stained cross-sections.
RESULTS: Mild inflammation and lower GFR was only observed in younger OZR, without renal fibrosis or changes in MV density. Interestingly, renal MV density increased in OZR at 32 weeks of age, accompanied by pronounced increase in renal IL-6 and TNF-alpha, ED-1+ cells, proteinuria, decreased GFR, and fibrosis.
CONCLUSIONS: This study shows increased renal cortical vascularization in experimental obesity, suggesting neovascularization as an evolving process as obesity progresses. Increased renal vascularization, possibly triggered by inflammation, may reflect an initially compensatory mechanism in obesity. However, increased inflammation and inflammatory-induced neovascularization may further promote renal injury as obesity advances.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536738      PMCID: PMC2924614          DOI: 10.1111/j.1549-8719.2010.00020.x

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  36 in total

1.  Impact of androgen-induced oxidative stress on hypertension in male SHR.

Authors:  Radu Iliescu; Valeria E Cucchiarelli; Licy L Yanes; Joshua W Iles; Jane F Reckelhoff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-07-20       Impact factor: 3.619

2.  Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension.

Authors:  Martin Rodriguez-Porcel; Xiang-Yang Zhu; Alejandro R Chade; Beatriz Amores-Arriaga; Noel M Caplice; Erik L Ritman; Amir Lerman; Lilach O Lerman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-07       Impact factor: 4.733

3.  Microcirculation: nexus of comorbidities in diabetes.

Authors:  Constance Temm; Jesus H Dominguez
Journal:  Am J Physiol Renal Physiol       Date:  2007-05-09

Review 4.  Role of oxidative stress in age-associated chronic kidney pathologies.

Authors:  Christine Percy; Betty Pat; Philip Poronnik; Glenda Gobe
Journal:  Adv Chronic Kidney Dis       Date:  2005-01       Impact factor: 3.620

Review 5.  The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.

Authors:  Laura Chalmers; Fredrick J Kaskel; Oluwatoyin Bamgbola
Journal:  Adv Chronic Kidney Dis       Date:  2006-10       Impact factor: 3.620

Review 6.  Renal disease in obesity: the need for greater attention.

Authors:  Przemyslaw Rutkowski; André Klassen; Katarina Sebekova; Udo Bahner; August Heidland
Journal:  J Ren Nutr       Date:  2006-07       Impact factor: 3.655

Review 7.  Obesity and renal hemodynamics.

Authors:  R J Bosma; J A Krikken; J J Homan van der Heide; P E de Jong; G J Navis
Journal:  Contrib Nephrol       Date:  2006       Impact factor: 1.580

Review 8.  Obesity and chronic kidney disease.

Authors:  Holly Kramer
Journal:  Contrib Nephrol       Date:  2006       Impact factor: 1.580

9.  Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-03-02       Impact factor: 17.586

10.  Tempol reduces oxidative stress, improves insulin sensitivity, decreases renal dopamine D1 receptor hyperphosphorylation, and restores D1 receptor-G-protein coupling and function in obese Zucker rats.

Authors:  Anees Ahmad Banday; Aditi Marwaha; Lakshmi S Tallam; Mustafa F Lokhandwala
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

View more
  26 in total

1.  Testosterone supplementation in male obese Zucker rats reduces body weight and improves insulin sensitivity but increases blood pressure.

Authors:  Deborah D Davis; Arnaldo Lopez Ruiz; Licy L Yanes; Radu Iliescu; Kuichang Yuan; Mohadetheh Moulana; Lorraine C Racusen; Jane F Reckelhoff
Journal:  Hypertension       Date:  2012-01-23       Impact factor: 10.190

Review 2.  Obesity and renovascular disease.

Authors:  Xin Zhang; Lilach O Lerman
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-03

3.  A kidney-selective biopolymer for targeted drug delivery.

Authors:  Gene L Bidwell; Fakhri Mahdi; Qingmei Shao; Omar C Logue; Jamarius P Waller; Caleb Reese; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-26

4.  Effect of the anti-oxidant tempol on fetal growth in a mouse model of fetal growth restriction.

Authors:  Joanna L Stanley; Irene J Andersson; Cassandra J Hirt; Linn Moore; Mark R Dilworth; Alejandro R Chade; Colin P Sibley; Sandra T Davidge; Philip N Baker
Journal:  Biol Reprod       Date:  2012-07-26       Impact factor: 4.285

5.  Transition from obesity to metabolic syndrome is associated with altered myocardial autophagy and apoptosis.

Authors:  Zi-Lun Li; John R Woollard; Behzad Ebrahimi; John A Crane; Kyra L Jordan; Amir Lerman; Shen-Ming Wang; Lilach O Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-01       Impact factor: 8.311

6.  Biopolymer-delivered vascular endothelial growth factor improves renal outcomes following revascularization.

Authors:  Erika Guise; Jason E Engel; Maxx L Williams; Fakhri Mahdi; Gene L Bidwell; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-20

7.  Distinct temporal phases of microvascular rarefaction in skeletal muscle of obese Zucker rats.

Authors:  Jefferson C Frisbee; Adam G Goodwill; Stephanie J Frisbee; Joshua T Butcher; Robert W Brock; I Mark Olfert; Evan R DeVallance; Paul D Chantler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-10-10       Impact factor: 4.733

8.  Microvascular disease precedes the decline in renal function in the streptozotocin-induced diabetic rat.

Authors:  Christine Maric-Bilkan; Elizabeth R Flynn; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2011-10-26

9.  Proximal tubule angiotensin AT2 receptors mediate an anti-inflammatory response via interleukin-10: role in renoprotection in obese rats.

Authors:  Isha Dhande; Quaisar Ali; Tahir Hussain
Journal:  Hypertension       Date:  2013-04-01       Impact factor: 10.190

10.  Recovery of Renal Function following Kidney-Specific VEGF Therapy in Experimental Renovascular Disease.

Authors:  Jason E Engel; Maxx L Williams; Erika Williams; Camille Azar; Erin B Taylor; Gene L Bidwell; Alejandro R Chade
Journal:  Am J Nephrol       Date:  2020-10-30       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.